company

GENO R&D AS

2317 HAMAR

Return on Equity
0,86 %
Current Ratio
2,47
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue3 100 000
Net Income14 000
Total Assets2 720 000
Total Equity1 619 000
Income (NOK)2022
Revenue3 100 000
Expenditure3 122 000
Operating Profit−22 000
Financial Income37 000
Financial Costs1 000
Financial Balance36 000
Earnings Before Tax14 000
Tax0
Net Income14 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets2 720 000
Total Assets2 720 000
Total Retained Equity719 000
Total Equity1 619 000
Total Long-Term Debt0
Total Current Debt1 100 000
Total Equity and Debt2 720 000
Cash flow (NOK)2022
Sales Income3 100 000
Other Income0
Revenue3 100 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure3 122 000
Operating Profit−22 000
Financial Income37 000
Financial Costs1 000
Financial Balance36 000
Dividends14 000
Net Income14 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank1 134 000
Total Current Assets2 720 000
Total Assets2 720 000
Total Equity1 619 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 100 000
Unpaid Taxes0
Dividends14 000
Other Current Debt0
Total Current Debt1 100 000
Total Equity and Debt2 720 000
Financial indicators2022
Return on Equity0,86 %
Debt-to-Equity Ratio0
Operating Profit Margin−0,71 %
Current Ratio2,47
Quick Ratio2,47
Equity Ratio0,6
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English